RT Journal Article
SR Electronic
T1 Novel oncolytic adenovirus expressing enhanced cross-hybrid IgGA Fc PD-L1 inhibitor activates multiple immune effector populations leading to enhanced tumor killing in vitro, in vivo and with patient-derived tumor organoids
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e003000
DO 10.1136/jitc-2021-003000
VO 9
IS 8
A1 Hamdan, Firas
A1 Ylösmäki, Erkko
A1 Chiaro, Jacopo
A1 Giannoula, Yvonne
A1 Long, Maeve
A1 Fusciello, Manlio
A1 Feola, Sara
A1 Martins, Beatriz
A1 Feodoroff, Michaela
A1 Antignani, Gabriella
A1 Russo, Salvatore
A1 Kari, Otto
A1 Lee, Moon Hee
A1 Järvinen, Petrus
A1 Nisen, Harry
A1 Kreutzman, Anna
A1 Leusen, Jeanette
A1 Mustjoki, Satu
A1 McWilliams, Thomas G
A1 Grönholm, Mikaela
A1 Cerullo, Vincenzo
YR 2021
UL http://jitc.bmj.com/content/9/8/e003000.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.